Cargando…
The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol
BACKGROUND: Children commonly present to Emergency Departments (ED) with a non-blanching rash in the context of a feverish illness. While most have a self-limiting viral illness, this combination of features potentially represents invasive serious bacterial infection, including meningococcal septica...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065062/ https://www.ncbi.nlm.nih.gov/pubmed/30060751 http://dx.doi.org/10.1186/s12887-018-1220-x |
_version_ | 1783342801181736960 |
---|---|
author | Waterfield, Thomas Lyttle, Mark D. Fairley, Derek Mckenna, James Woolfall, Kerry Lynn, Fiona Maney, Julie-Ann Roland, Damian Weir, Aoife Shields, Michael D. |
author_facet | Waterfield, Thomas Lyttle, Mark D. Fairley, Derek Mckenna, James Woolfall, Kerry Lynn, Fiona Maney, Julie-Ann Roland, Damian Weir, Aoife Shields, Michael D. |
author_sort | Waterfield, Thomas |
collection | PubMed |
description | BACKGROUND: Children commonly present to Emergency Departments (ED) with a non-blanching rash in the context of a feverish illness. While most have a self-limiting viral illness, this combination of features potentially represents invasive serious bacterial infection, including meningococcal septicaemia. A paucity of definitive diagnostic testing creates diagnostic uncertainty for clinicians; a safe approach mandates children without invasive disease are often admitted and treated with broad-spectrum antibiotics. Conversely, a cohort of children still experience significant mortality and morbidity due to late diagnosis. Current management is based on evidence which predates (i) the introduction of meningococcal B and C vaccines and (ii) availability of point of care testing (POCT) for procalcitonin (PCT) and Neisseria meningitidis DNA. METHODS: This PiC study is a prospective diagnostic accuracy study evaluating (i) rapid POCT for PCT and N. meningitidis DNA and (ii) performance of existing clinical practice guidelines (CPG) for feverish children with non-blanching rash. All children presenting to the ED with a history of fever and non-blanching rash are eligible. Children are managed as normal, with detailed prospective collection of data pertinent to CPGs, and a throat swab and blood used for rapid POCT. The study is running over 2 years and aims to recruit 300 children. Primary objective: Report on the diagnostic accuracy of POCT for (i) N. meningitidis DNA and (ii) PCT in the diagnosis of early MD. Report on the diagnostic accuracy of POCT for PCT in the diagnosis of Invasive bacterial infection. Secondary objectives: Evaluate the performance accuracy of existing CPGs. Evaluate cost-effectiveness of available diagnostic testing strategies. Explore views of (i) families and (ii) clinicians on research without prior consent using qualitative methodology. Report on the aetiology of NBRs in children with a feverish illness. DISCUSSION: The PiC study will provide important information for policy makers regarding the value of POCT and on the utility and cost of emerging diagnostic strategies. The study will also identify which elements of existing CPGs may merit inclusion in any future study to derive clinical decision rules for this population. TRIAL REGISTRATION: NCT03378258. Retrospectively registered on December 19, 2017. |
format | Online Article Text |
id | pubmed-6065062 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60650622018-08-01 The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol Waterfield, Thomas Lyttle, Mark D. Fairley, Derek Mckenna, James Woolfall, Kerry Lynn, Fiona Maney, Julie-Ann Roland, Damian Weir, Aoife Shields, Michael D. BMC Pediatr Study Protocol BACKGROUND: Children commonly present to Emergency Departments (ED) with a non-blanching rash in the context of a feverish illness. While most have a self-limiting viral illness, this combination of features potentially represents invasive serious bacterial infection, including meningococcal septicaemia. A paucity of definitive diagnostic testing creates diagnostic uncertainty for clinicians; a safe approach mandates children without invasive disease are often admitted and treated with broad-spectrum antibiotics. Conversely, a cohort of children still experience significant mortality and morbidity due to late diagnosis. Current management is based on evidence which predates (i) the introduction of meningococcal B and C vaccines and (ii) availability of point of care testing (POCT) for procalcitonin (PCT) and Neisseria meningitidis DNA. METHODS: This PiC study is a prospective diagnostic accuracy study evaluating (i) rapid POCT for PCT and N. meningitidis DNA and (ii) performance of existing clinical practice guidelines (CPG) for feverish children with non-blanching rash. All children presenting to the ED with a history of fever and non-blanching rash are eligible. Children are managed as normal, with detailed prospective collection of data pertinent to CPGs, and a throat swab and blood used for rapid POCT. The study is running over 2 years and aims to recruit 300 children. Primary objective: Report on the diagnostic accuracy of POCT for (i) N. meningitidis DNA and (ii) PCT in the diagnosis of early MD. Report on the diagnostic accuracy of POCT for PCT in the diagnosis of Invasive bacterial infection. Secondary objectives: Evaluate the performance accuracy of existing CPGs. Evaluate cost-effectiveness of available diagnostic testing strategies. Explore views of (i) families and (ii) clinicians on research without prior consent using qualitative methodology. Report on the aetiology of NBRs in children with a feverish illness. DISCUSSION: The PiC study will provide important information for policy makers regarding the value of POCT and on the utility and cost of emerging diagnostic strategies. The study will also identify which elements of existing CPGs may merit inclusion in any future study to derive clinical decision rules for this population. TRIAL REGISTRATION: NCT03378258. Retrospectively registered on December 19, 2017. BioMed Central 2018-07-30 /pmc/articles/PMC6065062/ /pubmed/30060751 http://dx.doi.org/10.1186/s12887-018-1220-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Waterfield, Thomas Lyttle, Mark D. Fairley, Derek Mckenna, James Woolfall, Kerry Lynn, Fiona Maney, Julie-Ann Roland, Damian Weir, Aoife Shields, Michael D. The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol |
title | The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol |
title_full | The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol |
title_fullStr | The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol |
title_full_unstemmed | The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol |
title_short | The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a study protocol |
title_sort | “petechiae in children” (pic) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for procalcitonin & neisseria meningitidis dna – a study protocol |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065062/ https://www.ncbi.nlm.nih.gov/pubmed/30060751 http://dx.doi.org/10.1186/s12887-018-1220-x |
work_keys_str_mv | AT waterfieldthomas thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT lyttlemarkd thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT fairleyderek thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT mckennajames thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT woolfallkerry thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT lynnfiona thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT maneyjulieann thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT rolanddamian thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT weiraoife thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT shieldsmichaeld thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT thepetechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT waterfieldthomas petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT lyttlemarkd petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT fairleyderek petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT mckennajames petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT woolfallkerry petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT lynnfiona petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT maneyjulieann petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT rolanddamian petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT weiraoife petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT shieldsmichaeld petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol AT petechiaeinchildrenpicstudyevaluatingpotentialclinicaldecisionrulesforthemanagementoffeverishchildrenwithnonblanchingrashesincludingtheroleofpointofcaretestingforprocalcitoninneisseriameningitidisdnaastudyprotocol |